June 03, 2020: "Pfizer Inc. announced that JAMA Dermatology has published complete results from the second Phase 3 monotherapy pivotal study (JADE MONO-2) of abrocitinib, an...
June 02, 2020:"The U.S. Food and Drug Administration announced the following actions taken in its ongoing response effort to the COVID-19 pandemic:
The agency issued...
June 02, 2020: "Pfizer announced that the establishment of the Pfizer Breakthrough Growth Initiative, through which Pfizer will invest up to $500 million in...
June 1, 2020: "AbbVie, a research-based global biopharmaceutical company, today announced that it has submitted applications for a new indication to the U.S. FDA...
June 01, 2020: "AbbVie, a research-based global biopharmaceutical company, and Jacobio Pharmaceuticals, a clinical-stage pharmaceutical company announced that a global, strategic collaboration to develop...
June 02, 2020: "The U.S. Food and Drug Administration announced the following actions taken in its ongoing response effort to the COVID-19 pandemic:
On May...
June 02, 2020: The EC has approved Sarclisa® (isatuximab) in combination with pomalidomide and dexamethasone (pom-dex) for the treatment of adult patients with relapsed and...
June 02, 2020: "Sanofi Chief Executive Officer Paul Hudson along with R&D and commercial leaders will provide an overview of Sanofi’s oncology strategy and...
June 02, 2020: "Roche announced that the US FDA has approved Tecentriq® (atezolizumab) in combination with Avastin® (bevacizumab) for the treatment of people with...